An update from Shockwave Medical (SWAV) is now available.
The recent merger of a company has triggered significant changes for note holders and stockholders, with the completion of the merger marking a fundamental change in the company’s structure. Note holders now have the right to require the repurchase of their notes or convert them for a pre-determined amount, while stockholders’ shares were converted into the right to receive merger consideration. Additionally, the merger led to the cessation of several stock plans, termination of a credit facility, and outstanding obligations were paid. The company also notified Nasdaq, halting the trading of company shares, and plans to terminate registration and reporting obligations. The merger resulted in a complete change of control, new company directors, and termination of certain executive roles, with Johnson & Johnson now holding all voting securities.
For a thorough assessment of SWAV stock, go to TipRanks’ Stock Analysis page.
